May 15 (Reuters)-
Daiken Medical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2026 Mar 31, 2025 Mar 31, 2027 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 10.29 9.95 10.50 5.15
(+3.4 pct) (+2.1 pct) (+2.0 pct) (+1.8 pct)
Operating 1.28 1.51 840 mln 400 mln
(-15.5 pct) (+4.8 pct) (-34.3 pct) (-40.8 pct)
Recurring 1.27 1.51 825 mln 395 mln
(-15.6 pct) (+4.1 pct) (-35.3 pct) (-41.5 pct)
Net 922 mln 1.10 590 mln 284 mln
(-15.9 pct) (+11.0 pct) (-36.1 pct) (-44.5 pct)
EPS 32.12 yen 38.21 yen 20.54 yen 9.89 yen
Ann Div 20.00 yen 23.00 yen 20.00 yen
-Q2 Div 9.00 yen 9.00 yen 9.00 yen
-Q4 Div 11.00 yen 14.00 yen 11.00 yen
NOTE - Daiken Medical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7775.T